• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别胶质瘤的分子亚类可预测预后,描绘疾病进展模式,并类似于神经发生的阶段。

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

作者信息

Phillips Heidi S, Kharbanda Samir, Chen Ruihuan, Forrest William F, Soriano Robert H, Wu Thomas D, Misra Anjan, Nigro Janice M, Colman Howard, Soroceanu Liliana, Williams P Mickey, Modrusan Zora, Feuerstein Burt G, Aldape Ken

机构信息

Department of Tumor Biology and Angiogenesis, Genentech, Inc., South San Francisco, California 94080, USA.

出版信息

Cancer Cell. 2006 Mar;9(3):157-73. doi: 10.1016/j.ccr.2006.02.019.

DOI:10.1016/j.ccr.2006.02.019
PMID:16530701
Abstract

Previously undescribed prognostic subclasses of high-grade astrocytoma are identified and discovered to resemble stages in neurogenesis. One tumor class displaying neuronal lineage markers shows longer survival, while two tumor classes enriched for neural stem cell markers display equally short survival. Poor prognosis subclasses exhibit markers either of proliferation or of angiogenesis and mesenchyme. Upon recurrence, tumors frequently shift toward the mesenchymal subclass. Chromosomal locations of genes distinguishing tumor subclass parallel DNA copy number differences between subclasses. Functional relevance of tumor subtype molecular signatures is suggested by the ability of cell line signatures to predict neurosphere growth. A robust two-gene prognostic model utilizing PTEN and DLL3 expression suggests that Akt and Notch signaling are hallmarks of poor prognosis versus better prognosis gliomas, respectively.

摘要

先前未描述的高级别星形细胞瘤预后亚类被识别出来,并发现其类似于神经发生的阶段。一个显示神经元谱系标志物的肿瘤类别生存期更长,而两个富含神经干细胞标志物的肿瘤类别生存期同样较短。预后不良的亚类表现出增殖、血管生成或间充质的标志物。复发时,肿瘤常转向间充质亚类。区分肿瘤亚类的基因的染色体位置与亚类之间的DNA拷贝数差异平行。细胞系特征预测神经球生长的能力提示了肿瘤亚型分子特征的功能相关性。一个利用PTEN和DLL3表达的强大的双基因预后模型表明,Akt和Notch信号分别是预后不良与预后较好的胶质瘤的标志。

相似文献

1
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.高级别胶质瘤的分子亚类可预测预后,描绘疾病进展模式,并类似于神经发生的阶段。
Cancer Cell. 2006 Mar;9(3):157-73. doi: 10.1016/j.ccr.2006.02.019.
2
Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.比较表达分析揭示了人类和鼠类神经胶质瘤之间的谱系关系,以及体外肿瘤传播过程中神经胶质特征的主导地位。
Cancer Res. 2013 Sep 15;73(18):5834-44. doi: 10.1158/0008-5472.CAN-13-1299. Epub 2013 Jul 25.
3
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.通过对 2016 年 WHO 弥漫性胶质瘤分类进行以下四项指标的细化:EGFR 扩增、TERT 突变、PTEN 缺失和 MGMT 甲基化,获得的临床见解。
BMC Cancer. 2019 Oct 17;19(1):968. doi: 10.1186/s12885-019-6177-0.
4
Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.miR-126 在胶质瘤中靶向调控 PTEN/PI3K/Akt 和 MDM2-p53 通路的研究。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3461-3470. doi: 10.26355/eurrev_201904_17711.
5
Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.反映癌症进展连续体异质性的胶质瘤分类分子投票法。
Oncol Rep. 2005 Sep;14(3):651-6.
6
High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.高表达的miR-196a和低表达的miR-367与高级别胶质瘤的不良预后协同相关。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6576-88. eCollection 2015.
7
Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.阐明神经胶质瘤的分子发病机制:家族性神经胶质瘤病例系列的整合胚系和体细胞分析。
Neuro Oncol. 2018 Nov 12;20(12):1625-1633. doi: 10.1093/neuonc/noy119.
8
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.胶质瘤的微阵列分析揭示了染色体位置相关的基因表达模式,并确定了潜在的免疫治疗靶点。
J Neurooncol. 2007 Oct;85(1):11-24. doi: 10.1007/s11060-007-9383-6. Epub 2007 Jul 17.
9
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.RAB38 预示着不良预后,与胶质瘤的恶性进展和亚型偏好相关。
Oncol Rep. 2013 Nov;30(5):2350-6. doi: 10.3892/or.2013.2730. Epub 2013 Sep 10.
10
Molecular subclassification of diffuse gliomas: seeing order in the chaos.弥漫性神经胶质瘤的分子分类:在混沌中寻找秩序。
Glia. 2011 Aug;59(8):1190-9. doi: 10.1002/glia.21165. Epub 2011 Mar 28.

引用本文的文献

1
The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications.核因子κB在胶质母细胞瘤中的关键作用:激活机制及治疗意义
Int J Mol Sci. 2025 Aug 15;26(16):7883. doi: 10.3390/ijms26167883.
2
MRI-defined patterns of infiltration and outcome in patients with glioblastoma.胶质母细胞瘤患者的MRI定义的浸润模式与预后
Neurooncol Adv. 2025 Jul 11;7(1):vdaf114. doi: 10.1093/noajnl/vdaf114. eCollection 2025 Jan-Dec.
3
Takeaways from meta-analysis: indications of combinational treatments for glioblastoma.
荟萃分析的要点:胶质母细胞瘤联合治疗的指征
J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05205-8.
4
Glioma-Associated Mesenchymal Stromal/Stem Cells Derived Exosomal miR-191 Promotes the Proneural-to-Mesenchymal Transition in Glioblastoma Cells via PTEN/PI3K/AKT Signaling.胶质瘤相关间充质基质/干细胞衍生的外泌体miR-191通过PTEN/PI3K/AKT信号通路促进胶质母细胞瘤细胞的神经干细胞样向间充质转变。
Int J Nanomedicine. 2025 Jul 7;20:8811-8831. doi: 10.2147/IJN.S515771. eCollection 2025.
5
A comprehensive analysis of transcription factors identified TCF3 as a prognostic target for glioma.对转录因子的全面分析确定TCF3为胶质瘤的一个预后靶点。
Sci Rep. 2025 Jul 13;15(1):25314. doi: 10.1038/s41598-025-09924-w.
6
Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2).探索外周巨噬细胞在胶质瘤进展中的作用:环氧合酶-2(COX-2)的代谢意义
Int J Mol Sci. 2025 Jun 27;26(13):6198. doi: 10.3390/ijms26136198.
7
CaMKK2 as a therapeutic target to combat metastasis in glioblastoma.钙调蛋白依赖性蛋白激酶2作为对抗胶质母细胞瘤转移的治疗靶点。
Mol Biol Rep. 2025 Jul 10;52(1):696. doi: 10.1007/s11033-025-10813-8.
8
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.处于十字路口的胶质母细胞瘤:当前的认识与未来的治疗前景
Signal Transduct Target Ther. 2025 Jul 9;10(1):213. doi: 10.1038/s41392-025-02299-4.
9
Regional profiling reveals a distinct glioblastoma infiltrative margin proteome.区域分析揭示了一种独特的胶质母细胞瘤浸润边缘蛋白质组。
Sci Rep. 2025 Jul 5;15(1):24021. doi: 10.1038/s41598-025-09228-z.
10
The reprogramming impact of SMAC-mimetic on glioblastoma stem cells and the immune tumor microenvironment evolution.SMAC模拟物对胶质母细胞瘤干细胞的重编程影响及免疫肿瘤微环境演变
J Exp Clin Cancer Res. 2025 Jul 4;44(1):191. doi: 10.1186/s13046-025-03452-1.